Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Barcoding intracellular reverse transcription enables high-throughput phenotype-coupled T cell receptor analyses

Cell Reports Methods(2023)10.1016/j.crmeth.2023.100600Source: DataRank Database

Barcoding intracellular reverse transcription enables high-throughput phenotype-coupled T cell receptor analyses is a research paper published in Cell Reports Methods (2023). On theSindex it has a DataRank of 0.165. It has been cited 2 times.

N/A

0.165DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (22 grants)Impact (FWCI 0.18)OA: goldTopics (46)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.165

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (15)

Janelle M. Montagne ORCID,Thomas R. Nirschl ORCID,Emily F. Davis-Marcisak ORCID,Jeanette Johnson ORCID,Amanda L. Huff ORCID

Live enrichment

PubMed:37776855 PMC:PMC10626196 OpenAlex:https://openalex.org/W4387190354

NCI NIH HHS

Grant: K08 CA248624

NCI NIH HHS

Grant: P30 CA006973

NCI NIH HHS

Grant: P50 CA062924

NIAID NIH HHS

Grant: U24 AI118633

NCI NIH HHS

Grant: P01 CA247886

NIGMS NIH HHS

Grant: T32 GM136577

NCI NIH HHS

Grant: F31 CA250135

NCI NIH HHS

Grant: K22 CA237623

NCI NIH HHS

Grant: F32 CA271470

NCI NIH HHS

Grant: R01 CA197296

NCI NIH HHS

Grant: T32 CA009110

NCI NIH HHS

Grant: U01 CA253403

National Institutes of Health

Grant: 5K22CA237623-03

Targeting M2-Tumor Associated Macrophages to overcome tumor immunity in metastatic castration-resistant prostate cancer

National Institutes of Health

Grant: 1K08CA248624-01A1

Neoantigen-Targeted Vaccines in Combination with Immune Checkpoint Inhibitors for Pancreatic Cancer

National Institutes of Health

Grant: 2T32CA009110-21

TRAINING IN AREAS FUNDAMENTAL TO CANCER RESEARCH

National Institutes of Health

Grant: 5F31CA250135-02

T cell mechanisms of immunotherapy response in pancreatic ductal adenocarcinoma

National Institutes of Health

Grant: 5P50CA062924-25

SPORE in Gastrointestinal Cancers

National Institutes of Health

Grant: 3P30CA006973-53S2

Regional Oncology Research Center

National Institutes of Health

Grant: 1U01CA253403-01

Single-cell and imaging data integration software to spatially resolve the tumor microenvironment

National Institutes of Health

Grant: 5U24AI118633-03

Development of Highly Multiplex Antigen Specificity Assays

National Institutes of Health

Grant: 1F32CA271470-01

Structural modeling of neoantigen presentation for rational design of heteroclitic neoepitope vaccines

National Institutes of Health

Grant: 1P01CA247886-01A1

Transforming Human Pancreatic Cancer Into An Immunologic Disease

FWCI

0.18

Citation Percentile

0.5%

Citation Trend

2024

2026

goldLicense: cc-by

journalhttps://doi.org/10.1016/j.crmeth.2023.100600

publisherhttps://doi.org/10.1016/j.crmeth.2023.100600

publisherhttps://api.elsevier.com/content/article/PII:S2667237523002527?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2667237523002527?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37776855

Fields of Study

Single-cell and spatial transcriptomicsCAR-T cell therapy researchT-cell and B-cell Immunology0303 health sciences03 medical and health sciences

MeSH Terms

HumansLeukocytes, MononuclearReceptors, Antigen, T-CellReceptors, Antigen, T-Cell, alpha-betaCD8-Positive T-LymphocytesReverse Transcription

Keywords

Cell sortingT-cell receptorBiologyComputational biologyAntigenCD8PhenotypeT cellPeripheral blood mononuclear cellCellMolecular biologyCell biologyImmune systemGeneticsGeneIn vitroadaptive immunityAntigen ReceptorsRepertoire SequencingCp: ImmunologyCp: Systems BiologyMutant KrasScienceReceptors, Antigen, T-Cell, alpha-betaQReceptors, Antigen, T-CellQD415-436Reverse TranscriptionCD8-Positive T-LymphocytesBiochemistryReportLeukocytes, MononuclearHumansTP248.13-248.65Biotechnology

Sustainable Development Goals

SDG 0: Good health and well-being

Barcoding intracellular reverse transcription enables high-throughput phenotype-coupled T cell receptor analyses

FAIR Checklist

DataRank Breakdown

Authors (15)

Funding (22 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)